Timothy Kubal
Direktor/Vorstandsmitglied bei The Leukemia & Lymphoma Society, Inc.
Profil
Timothy Kubal is currently the Director at Fighting Cancer Network, Inc. and a Member-Suncoast Chapter Board of Trustees at The Leukemia & Lymphoma Society, Inc. He was previously the Medical Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc.
Aktive Positionen von Timothy Kubal
| Unternehmen | Position | Beginn |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Direktor/Vorstandsmitglied | - |
Fighting Cancer Network, Inc.
 Fighting Cancer Network, Inc. Packaged SoftwareTechnology Services Fighting Cancer Network, Inc. is an American company that provides a mobile application with video content and resources for cancer patients. The app currently focuses on breast cancer and prostate cancer, with plans to expand to other types of cancer in the future. The company was founded by Matt Scalici and Mike Ousley, with Matt Scalici serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Timothy Kubal
| Unternehmen | Position | Ende |
|---|---|---|
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
Fighting Cancer Network, Inc.
Fighting Cancer Network, Inc. Packaged SoftwareTechnology Services Fighting Cancer Network, Inc. is an American company that provides a mobile application with video content and resources for cancer patients. The app currently focuses on breast cancer and prostate cancer, with plans to expand to other types of cancer in the future. The company was founded by Matt Scalici and Mike Ousley, with Matt Scalici serving as the CEO since incorporation. | Technology Services |
